Health Condition 1: A419- Sepsis, unspecified organism
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Indian Council of Medical Research (ICMR)
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients hospitalized with clinical diagnosis of community-acquired sepsis (CAS), along with previously or newly diagnosed diabetes mellitus and/or chronic kidney diseases will be included in the study.
Exclusion criteria
Exclusion criteria: Pediatric patients, pregnant women, and patients who do not give consent to do the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study will help in: • Understanding the microbial pathogens associated with community acquired sepsis in high risk patients and the prevalence of melioidosis in these patients. • Understanding the antimicrobial susceptibility of the implicating pathogens in the study population which will guide treatment. Timepoint: Assessment will be done at baseline, 4 weeks, and 8 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Identify the risk factors and various patterns of clinical presentations and antimicrobial susceptibility pattern of melioidosis in our patient population which will help clinicians and microbiologists to have a broader view of the whole disease and to keep up a high index of suspicion while dealing with patients, which is very essential in diagnosis and treatment of this condition. Timepoint: Assessment will be done at baseline, 4 weeks, and 8 weeks. | — |
Countries
India
Contacts
Public ContactDr Vandana KE
Kasturba Medical College, Manipal
Outcome results
None listed